Adverum Biotechnologies, Inc(NASDAQ:ADVM) 
Adverum Biotechnologies, Inc., a clinical-stage gene therapy company, develops gene therapy product candidates to treat ocular and rare diseases. Its lead product candidate is ADVM-022, a single intravitreal injection gene therapy candidate used for the treatment of patients with chronic retinal dis...
Website: http://www.adverum.com
Founded: 2006
Full Time Employees: 114
Sector: Healthcare
Industry: Biotechnology
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2025-04-04
P
O 3.79
H 4.01
L 3.76
C 3.86
V 142,274
10EMA 3.86
20EMA 3.86
60EMA 3.86
120EMA 3.86
250EMA 3.86